175 related articles for article (PubMed ID: 24187330)
1. Cost-effectiveness analysis of cochlear dose reduction by proton beam therapy for medulloblastoma in childhood.
Hirano E; Fuji H; Onoe T; Kumar V; Shirato H; Kawabuchi K
J Radiat Res; 2014 Mar; 55(2):320-7. PubMed ID: 24187330
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma.
Mailhot Vega RB; Kim J; Bussière M; Hattangadi J; Hollander A; Michalski J; Tarbell NJ; Yock T; MacDonald SM
Cancer; 2013 Dec; 119(24):4299-307. PubMed ID: 24105630
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Proton Versus Photon Therapy in Pediatric Medulloblastoma Treatment: A Patient Volume-Based Analysis.
Fernandes RRA; Vianna CMM; Guerra RL; Cancela MC; Almeida LM; Pereira AJDC; Viégas CMP; Ferman SE; Corrêa F
Value Health Reg Issues; 2019 Dec; 20():122-128. PubMed ID: 31319299
[TBL] [Abstract][Full Text] [Related]
4. Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy.
Paulino AC; Mahajan A; Ye R; Grosshans DR; Fatih Okcu M; Su J; McAleer MF; McGovern S; Mangona VA; Chintagumpala M
Radiother Oncol; 2018 Jul; 128(1):128-132. PubMed ID: 29373195
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma.
Lundkvist J; Ekman M; Ericsson SR; Jönsson B; Glimelius B
Cancer; 2005 Feb; 103(4):793-801. PubMed ID: 15637691
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China.
Li G; Qiu B; Huang YX; Doyen J; Bondiau PY; Benezery K; Xia YF; Qian CN
BMC Cancer; 2020 Jun; 20(1):599. PubMed ID: 32590957
[TBL] [Abstract][Full Text] [Related]
7. [Clinical Evaluation of Proton Therapy - How much benefit can be considered a benefit?].
Combs SE
Strahlenther Onkol; 2016 Jul; 192(7):498-9. PubMed ID: 27272659
[No Abstract] [Full Text] [Related]
8. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
[TBL] [Abstract][Full Text] [Related]
9. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
Yock TI; Yeap BY; Ebb DH; Weyman E; Eaton BR; Sherry NA; Jones RM; MacDonald SM; Pulsifer MB; Lavally B; Abrams AN; Huang MS; Marcus KJ; Tarbell NJ
Lancet Oncol; 2016 Mar; 17(3):287-298. PubMed ID: 26830377
[TBL] [Abstract][Full Text] [Related]
10. Estimated clinical benefit of protecting neurogenesis in the developing brain during radiation therapy for pediatric medulloblastoma.
Blomstrand M; Brodin NP; Munck Af Rosenschöld P; Vogelius IR; Sánchez Merino G; Kiil-Berthlesen A; Blomgren K; Lannering B; Bentzen SM; Björk-Eriksson T
Neuro Oncol; 2012 Jul; 14(7):882-9. PubMed ID: 22611031
[TBL] [Abstract][Full Text] [Related]
11. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.
Giantsoudi D; Seco J; Eaton BR; Simeone FJ; Kooy H; Yock TI; Tarbell NJ; DeLaney TF; Adams J; Paganetti H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):37-46. PubMed ID: 28587051
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the Cost-Effectiveness of Hydrogel Rectal Spacer in Prostate Cancer Radiation Therapy.
Levy JF; Khairnar R; Louie AV; Showalter TN; Mullins CD; Mishra MV
Pract Radiat Oncol; 2019 Mar; 9(2):e172-e179. PubMed ID: 30342180
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the radiation therapy dose prescription for pediatric medulloblastoma: minimizing the life years lost attributable to failure to control the disease and late complication risk.
Brodin NP; Vogelius IR; Björk-Eriksson T; Munck Af Rosenschöld P; Maraldo MV; Aznar MC; Specht L; Bentzen SM
Acta Oncol; 2014 Apr; 53(4):462-70. PubMed ID: 24274390
[TBL] [Abstract][Full Text] [Related]
14. Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness.
Li G; Xia YF; Huang YX; Okat D; Qiu B; Doyen J; Bondiau PY; Benezery K; Gao J; Qian CN
BMC Cancer; 2021 Aug; 21(1):944. PubMed ID: 34419008
[TBL] [Abstract][Full Text] [Related]
15. NHS will pay for boy's proton beam therapy in Prague.
Dyer C
BMJ; 2014 Sep; 349():g5944. PubMed ID: 25270423
[No Abstract] [Full Text] [Related]
16. Hippocampal sparing radiotherapy for pediatric medulloblastoma: impact of treatment margins and treatment technique.
Brodin NP; Munck af Rosenschöld P; Blomstrand M; Kiil-Berthlesen A; Hollensen C; Vogelius IR; Lannering B; Bentzen SM; Björk-Eriksson T
Neuro Oncol; 2014 Apr; 16(4):594-602. PubMed ID: 24327585
[TBL] [Abstract][Full Text] [Related]
17. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Preoperative Treatment of Extremity Soft Tissue Sarcomas.
Richard P; Phillips M; Smith W; Davidson D; Kim E; Kane G
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):999-1008. PubMed ID: 27130792
[TBL] [Abstract][Full Text] [Related]
19. Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury.
Giantsoudi D; Sethi RV; Yeap BY; Eaton BR; Ebb DH; Caruso PA; Rapalino O; Chen YE; Adams JA; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):287-296. PubMed ID: 26691786
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis using lifetime attributable risk of proton beam therapy for pediatric medulloblastoma in Japan.
Yoshimura T; Tamori H; Morii Y; Hashimoto T; Shimizu S; Ogasawara K
J Radiat Res; 2021 Sep; ():. PubMed ID: 34590123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
